Integra LifeSciences Holdings (IART)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $1.12B
Last updated: Nov 17, 2026 at 11:06 AM ET
Integra LifeSciences Holdings (IART) P/E Ratio & Valuation History
Integra LifeSciences Holdings (IART) trades at 5.5x trailing earnings and 0.7x sales. Its P/E of 5.5x is below its 5-year median of 10.5x. Its forward P/E is 5.9x. The median P/E across 6 similar companies is 34.6x.
Current Multiples
Its forward P/E is above its trailing P/E, which implies earnings per share about 6.8% lower over the next year. Its free cash flow yield is 7.9%.
| Multiple | Value |
|---|---|
| P/E (trailing) | 5.5x |
| Forward P/E | 5.9x |
| Price to sales | 0.7x |
| Price to book | 1.0x |
| EV/EBITDA | 11.1x |
| Price to FCF | 12.6x |
| EV/FCF | 32.8x |
| PEG | 0.7 |
| FCF yield | 7.9% |
Historical Medians
Against its 10-year medians, its P/E is 71.8% below 19.5x, its P/S is 76.7% below 3.0x and its P/B is 66.7% below 3.0x.
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/E | 5.5x | 10.5x | 19.5x |
| P/S | 0.7x | 1.6x | 3.0x |
| P/B | 1.0x | 1.5x | 3.0x |
Valuation History
Over the 10 year ends shown, its P/E ranged from 5.6x in 2025 to 26.5x in 2020. 2025 was the lowest of those years.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $12.42 | 5.6x | 0.6x | 0.9x |
| 2024 | $22.68 | 8.9x | 1.1x | 1.1x |
| 2023 | $43.55 | 14.0x | 2.3x | 2.1x |
| 2022 | $56.07 | 16.7x | 3.0x | 2.6x |
| 2021 | $66.99 | 21.1x | 3.7x | 3.4x |
| 2020 | $64.92 | 26.5x | 4.0x | 3.6x |
| 2019 | $58.28 | 21.3x | 3.3x | 3.6x |
| 2018 | $45.10 | 18.6x | 2.5x | 2.8x |
| 2017 | $47.86 | 24.8x | 3.1x | 4.0x |
| 2016 | $42.90 | 24.4x | N/A | 4.1x |
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About IART
What is IART's forward P/E ratio?
Integra LifeSciences Holdings has a forward P/E ratio of 5.9x.
Is IART stock overvalued?
GNG's valuation label for IART is Undervalued. Its P/E of 5.5x compares with a median of 34.6x across 6 similar companies.
What is IART's price to sales ratio?
Integra LifeSciences Holdings has a price to sales ratio of 0.7x.
What is Integra LifeSciences Holdings's average P/E ratio over 5 years?
Integra LifeSciences Holdings's median P/E over the last 5 years is 10.5x, from 60 month-end values through Oct 2026.
What is IART's PEG ratio?
Integra LifeSciences Holdings has a PEG ratio of 0.7.
IART pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors